We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | EU:SAN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.21 | 0.23% | 90.21 | 90.21 | 90.23 | 90.22 | 89.56 | 90.09 | 114,041 | 11:13:55 |
From May 2021 to May 2024
By Ian Walker
Syncona Ltd. said Monday that Sanofi has agreed to invest up to $60 million in its portfolio company Gyroscope Therapeutics Holdings PLC.
The London-listed life-sciences investment company said that the French pharma major will initially invest $40 million in Gyroscope with the rest subject to a future investment round.
Sanofi will be entitled to appoint a research and development executive to Gyroscope's clinical advisory board to advise on Gyroscope's GT005 gene therapy. It will also have first refusal on certain potential deals for GT005 in select geographies.
Syncona will retain a 49% shareholding in Gyroscope following Sanofi's initial investment.
Shares at 1337 GMT were up 9.30 pence, or 4.7%, at 208.50 pence.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
November 08, 2021 08:52 ET (13:52 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
